The WHO has added GLP-1 agonists to its Essential Medicines List in 2025. Learn more about the impact of this decision.

At the European Cell & Gene Therapy Summit 2025, funding challenges and innovation drove discussions on the sector’s future.

Discover how in some communities around the world, the prevalence of rare diseases is higher due to factors like cousin ...

Gene therapies have seen a drop in investor interest lately. Despite this, Kriya Therapeutics seems to be attracting funds in ...

Discover the top biotech deals of August 2025, as several big pharmas shopped around, especially in the field of small ...

Learn how multichain biotherapeutics overcome manufacturing challenges with advanced expression vector design.

As the release of a CRL declining Lykos' therapy generates a strong reaction from MAPS, delve into what this new transparency ...

Abogen Biosciences makes it on this list by virtue of an impressive $700 million series C round that it bagged in August 2021 – still one of the biggest ever private biotech funding rounds. This was ...

Two months after ExCellThera’s Zemcelpro (UM171 cell therapy) received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP), the European ...

This session highlights recent innovations and practical strategies in antimalarial drug discovery, including advanced screening techniques, novel compound development, and data-driven decision-making ...